1. Home
  2. NIO vs HALO Comparison

NIO vs HALO Comparison

Compare NIO & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NIO
  • HALO
  • Stock Information
  • Founded
  • NIO 2014
  • HALO 1998
  • Country
  • NIO China
  • HALO United States
  • Employees
  • NIO N/A
  • HALO N/A
  • Industry
  • NIO Auto Manufacturing
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NIO Consumer Discretionary
  • HALO Health Care
  • Exchange
  • NIO Nasdaq
  • HALO Nasdaq
  • Market Cap
  • NIO 7.4B
  • HALO 7.4B
  • IPO Year
  • NIO 2018
  • HALO N/A
  • Fundamental
  • Price
  • NIO $3.52
  • HALO $58.79
  • Analyst Decision
  • NIO Hold
  • HALO Buy
  • Analyst Count
  • NIO 6
  • HALO 9
  • Target Price
  • NIO $5.05
  • HALO $61.63
  • AVG Volume (30 Days)
  • NIO 61.9M
  • HALO 1.8M
  • Earning Date
  • NIO 06-05-2025
  • HALO 05-06-2025
  • Dividend Yield
  • NIO N/A
  • HALO N/A
  • EPS Growth
  • NIO N/A
  • HALO 63.33
  • EPS
  • NIO N/A
  • HALO 3.43
  • Revenue
  • NIO $9,005,433,398.00
  • HALO $1,015,324,000.00
  • Revenue This Year
  • NIO $37.33
  • HALO $20.06
  • Revenue Next Year
  • NIO $25.76
  • HALO $24.04
  • P/E Ratio
  • NIO N/A
  • HALO $17.14
  • Revenue Growth
  • NIO 18.18
  • HALO 22.44
  • 52 Week Low
  • NIO $3.02
  • HALO $37.73
  • 52 Week High
  • NIO $7.71
  • HALO $66.00
  • Technical
  • Relative Strength Index (RSI)
  • NIO 39.90
  • HALO 44.06
  • Support Level
  • NIO $3.42
  • HALO $57.50
  • Resistance Level
  • NIO $3.71
  • HALO $62.14
  • Average True Range (ATR)
  • NIO 0.22
  • HALO 2.90
  • MACD
  • NIO 0.01
  • HALO -0.40
  • Stochastic Oscillator
  • NIO 51.02
  • HALO 36.41

About NIO NIO Inc. American depositary shares each representing one ordinary share

Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: